Research Study

A Multinational, Phase 3, Randomized, Double Blind, Placebo Controlled, Efficacy and Safety Study of Enzalutamide in Patients With Nonmetastatic Castration Resistant Prostate Cancer
Principal Investigator 
Martin Gleave

Overview

Body Locations and Systems 
Prostate Cancer
ClinicalTrials.gov# 
NCT02003924
Status 
Recruiting
Study Start/End 
Jan 24, 2014 to Jan 10, 2019
Locations 
Diamond Health Care Centre, Vancouver General Hospital
Name/Title 
Maureen Palmer, Research Coordinator
Phone 
604-875-5675
Purpose of Study 

The purpose of this study is to assess the safety and efficacy of enzalutamide in patients with non metastatic prostate cancer.

Eligibility 

Visit ClinicalTrials.gov for more information. 

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.